SWOG clinical trial number
SWOG-8321

Evaluation of Carboplatin Versus Cisplatinum + Infusion 5-Fluorouracil + Allopurinol in the Treatment of Metastatic Squamous Carcinoma of the Uterine Cervix

Closed
Phase
Published
Abbreviated Title
Evaluation of Carboplatin Versus Cisplatinum + Infusion 5-Fluorouracil + Allopurinol in the Treatment of Metastatic Squamous Carcinoma of the Uterine Cervix
Activated
12/07/1984
Closed
05/01/1988

Publication Information Expand/Collapse

1990

A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix. A Southwest Oncology Group trial.

GR Weiss;S Green;EV Hannigan;JG Boutselis;EA Surwit;DL Wallace;DS Alberts Gyn Onc 37:354-358

A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: A Southwest Oncology Group study.

GR Weiss;S Green;EV Hannigan;JG Boutselis;EA Surwit;SL Wallace;DS Alberts Gyn Onc 39:332-335

1989

Phase II trial of cisplatin (CP) and 5-fluorouracil (5FU) with or without allopurinol (ALL) for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: A Southwest Oncology Group study.

GR Weiss;S Green;D Stock-Novack;DS Alberts;R Giudice ASCO 8:158(#616)